Blueprint Medicines Corporation announced that Kate Haviland, Chief Executive Officer, will present a corporate overview and 2025 outlook at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 9:00 a.m. PT (12:00 p.m. ET).
HealthTech Insights: Hawkeye Group Announces the Launch of ClenchAlert Discrete Solution for Jaw Tension: A New Way to Combat Unconscious Teeth Clenching and Grinding
A live webcast of the presentation will be available by visiting the Investors & Media section of Blueprint Medicines’ website at http://ir.blueprintmedicines.com. A replay of the webcast will be archived on Blueprint Medicines’ website for 30 days following the presentation.
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire